PAIN RELIEVING PATCH ULTRA STRENGTH
- Manufacturer
- CVS PHARMACY, INC.
- Effective date
- 2013-09-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 17
- Source
- full-release
- Hydrated at
- 2026-05-31 22:37:03
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredient
Menthol 5%
OTC - PURPOSE SECTION
Purpose
Topical Analgesic
INDICATIONS & USAGE SECTION
Uses
Temporarily relieves minor aches and pains of muscles and joints associated with:
- arthritis
- simple backache
- strains
- sprains
- bruises
WARNINGS SECTION
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use
- on wounds or damaged skin
- with a heating pad
- on a child under 12 years of age with arthritis-like conditions
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you
- have redness over the affected area
- are pregnant or breastfeeding
OTC - WHEN USING SECTION
When using this product
- avoid contact with eyes and mucous membranes
- do not bandage tightly
- do not use with a heating pad or other heating device
OTC - STOP USE SECTION
Stop using this product if
- condition worsens
- excessive skin irritation occurs
- redness is present
- symptoms persist more than 7 days or clear up and occur again within a few days
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- open pouch and remove patch
- if desired, cut patch to size
- peel off protective backing and apply sticky side to affected area
- adults and children 12 years of age and older apply to affected area no more than 3 to 4 times daily
- children under 12 years of age consult a doctor
- For best results, please ensure that the skin is clean and dry before applying
- reseal pouch
INACTIVE INGREDIENT SECTION
Inactive Ingredients BHT, castor oil, cellulose gum, disodium edetate, glycerin, isopropyl myristate, kaolin, magnesium aluminometasilicate, methylparaben, PEG-4 stearate, polyacrylic acid, polysorbate 80, polyvinyl alcohol, purified water, sodium polyacrylate, tartaric acid, titanium dioxide. Release Liner: polyethylene, Non-Woven Material: polyester non-woven fabric.
OTC - QUESTIONS SECTION
Questions? Call toll-free 1-800-645-3867
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59779-991-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0714-f424-e053-dadaa90a57ce | Menthol 5% (Topical Analgesic) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59779-991-01 | PAIN RELIEVING PATCH ULTRA STRENGTH ULTRA STRENGTH | 1 g in 1 PATCH | PATCH | 1 | 17 | |
| 59779-991-01 | PAIN RELIEVING PATCH ULTRA STRENGTH ULTRA STRENGTH | 5 in 1 BOX | PATCH | 5 | 17 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 17 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 17 | |
| Butylated Hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | 17 | |
| Carboxymethylcellulose Sodium | INACTIVE INGREDIENT | K679OBS311 | 17 | |
| Castor Oil | INACTIVE INGREDIENT | D5340Y2I9G | 17 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | 17 | |
| Gelatin | INACTIVE INGREDIENT | 2G86QN327L | 17 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 17 | |
| Isopropyl Myristate | INACTIVE INGREDIENT | 0RE8K4LNJS | 17 | |
| Kaolin | INACTIVE INGREDIENT | 24H4NWX5CO | 17 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 17 | |
| Peg-4 Stearate | INACTIVE INGREDIENT | J33E8608YN | 17 | |
| Polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 17 | |
| Polyvinyl Alcohol | INACTIVE INGREDIENT | 532B59J990 | 17 | |
| Silodrate | INACTIVE INGREDIENT | 9T3UU8T0QK | 17 | |
| Tartaric Acid | INACTIVE INGREDIENT | W4888I119H | 17 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 17 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 17 |
Products#
Every source-derived product name is available through these pages.
- PAIN RELIEVING PATCH ULTRA STRENGTH ULTRA STRENGTH
- MENTHOL
- Silodrate
- Butylated Hydroxytoluene
- Castor Oil
- Carboxymethylcellulose Sodium
- Edetate Disodium
- Gelatin
- Glycerin
- Isopropyl Myristate
- Kaolin
- Methylparaben
- Peg-4 Stearate
- Polysorbate 80
- Polyvinyl Alcohol
- Water
- Tartaric Acid
- Titanium Dioxide
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 59779-991 | 59779-991-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Silodrate | 9T3UU8T0QK | IACT |
| Butylated Hydroxytoluene | 1P9D0Z171K | IACT |
| Castor Oil | D5340Y2I9G | IACT |
| Carboxymethylcellulose Sodium | K679OBS311 | IACT |
| Edetate Disodium | 7FLD91C86K | IACT |
| Gelatin | 2G86QN327L | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Isopropyl Myristate | 0RE8K4LNJS | IACT |
| Kaolin | 24H4NWX5CO | IACT |
| Methylparaben | A2I8C7HI9T | IACT |
| Peg-4 Stearate | J33E8608YN | IACT |
| Polysorbate 80 | 6OZP39ZG8H | IACT |
| Polyvinyl Alcohol | 532B59J990 | IACT |
| Water | 059QF0KO0R | IACT |
| Tartaric Acid | W4888I119H | IACT |
| Titanium Dioxide | 15FIX9V2JP | IACT |
| Menthol | L7T10EIP3A | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Silodrate | SILODRATE | 9T3UU8T0QK | TABLET / ORAL | 11 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / OPHTHALMIC | 1 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, FILM COATED / ORAL | 50 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RESPIRATORY (INHALATION) | 0.03 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAVENOUS | 7 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| Kaolin | KAOLIN | 24H4NWX5CO | POWDER, FOR SUSPENSION / ORAL | NA | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GUM, CHEWING / BUCCAL | 5 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | AEROSOL, FOAM / VAGINAL | 0.2 %w/w | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 8 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| Polyvinyl Alcohol | POLYVINYL ALCOHOL | 532B59J990 | SOLUTION / OPHTHALMIC | 6 mg | ||
| Polyvinyl Alcohol | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION / OPHTHALMIC | 1.4 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Kaolin | KAOLIN | 24H4NWX5CO | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 234 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | LOTION / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | JELLY / NASAL | 250 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | DROPS / OPHTHALMIC | 0.05 %w/w | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | LOTION / TOPICAL | 50 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | AEROSOL, FOAM / TOPICAL | 0.98 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CREAM / VAGINAL | 0.4 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | EMULSION / TOPICAL | 0.2 %w/w | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | ENEMA / RECTAL | 0.01 %w/v | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / RECTAL | 1 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, CHEWABLE / ORAL | 84 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE, LIQUID FILLED / ORAL | 0.1 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | LIQUID / INTRAVENOUS | 720 mg | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL / TOPICAL | 29 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / SUBCUTANEOUS | 2 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | EMULSION / TOPICAL | 34050 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 1 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | SPRAY / NASAL | NA | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / RECTAL | 315 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 100 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / IONTOPHORESIS | 0.1 mg | ||
| Tartaric Acid | TARTARIC ACID | W4888I119H | CAPSULE / ORAL | 400 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, CHEWABLE / ORAL | 1 mg | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE, COATED / ORAL | 288 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | 126 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| Tartaric Acid | TARTARIC ACID | W4888I119H | TABLET / ORAL | 63 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | GEL / VAGINAL | 5 mg | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE, COATED PELLETS / ORAL | 65 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| Tartaric Acid | TARTARIC ACID | W4888I119H | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 11 mg | ||
| Kaolin | KAOLIN | 24H4NWX5CO | CAPSULE / ORAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bcbfe1f1-6e96-4f45-bd96-79a84b94e193 | 189c313d-f0a3-4593-852e-addbe9082524 | 2013-09-18 | Warnings | bcbfe1f1-6e96-4f45-bd96-79a84b94e193 189c313d-f0a3-4593-852e-addbe9082524 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

